Surprised that the national average rate that employer-sponsored health plans pay hospitals is 2.5-times higher than Medicare’s reimbursement rate? Or that there is actually no relationship between the volume of publicly covered patients a hospital serves to the prices it charges commercially-insured patients? This price transparency is important as states and employers work to rein in health care spending, but what do health care purchasers know about a hospital’s costs for providing patient care?
The Hospital Cost Tool developed by the National Academy for State Health Policy (NASHP) with support from Arnold Ventures can be used as a complement to recent findings reported in RAND Corp.’s Nationwide Evaluation of Health Care Prices Paid by Private Health Plans to help purchasers and regulators better understand hospitals’ costs, their public and commercial payer mix, and their cost recovery from Medicare, Medicaid, and commercial payers.
State officials responsible for cost containment strategies, including administrators of state employee health plans, and employers can use NASHP’s hospital cost tool to understand the relationship between health plans’ hospital payments and the hospital’s reported costs. Understanding the difference between a hospitals’ costs and the payments it receives is critical data that can be used to initiate informed conversations about appropriate payment reimbursements.
The tool uses Medicare cost report (MCR) data that is annually submitted by hospitals to the federal government to calculate a number of cost variables for individual hospitals, including cost-to-charge ratios, profit margin, and more. There is no additional reporting burden on hospitals for states and employers to use this tool. The tool includes detailed instructions and has embedded formulas to help users access and leverage critical information from MCRs, which are often hundreds of pages long for each hospital. The MCR is the only nationally available, public information that provides hospital cost data.
The federal reporting instructions are standard for all hospitals so the information in each hosptial’s MCR is comparable across hospitals. While all hospitals receiving Medicare payments must submit these reports to the federal government, some may be hard to find. Some states require hospitals to submit their MCRs to a certain state agency that is permitted access to the data. Also, there are organizations that provide these reports in a well-organized manner for a fee (annual and/or per hospital MCR). For more information on MCRs, read the NASHP blog, Why Compare What Employers Pay to What Medicare Pays?
While the tool can be used to analyze hosptials’ costs, it is not currently designed to provide analysis about a hospital’s level of efficiency or whether the costs are appropriate given the quality of care provided. However, because the tool uses the MCR data, comparing multiple hospitals is one way to account for efficiency. For example, in comparing two hospitals in a state, if the data from Hospital A shows that Medicare covers 88 percent of its costs, and at Hospital B Medicare covers 103 percent of its costs, that could indicate that hospital B uses its reimbursements more efficiently to provide patient care.
However, there may be additional criteria to consider— some of which is highlighted in the tool – such as payer mix. The tool uses weighted data to account for each payer’s proportion of the population served by the hospital so that comparisons across hospitals with different payer mixes can be made. But, other considerations may be necessary. For example, it may useful to review a hospital’s MCR data over time using the tool to identify a cost trend. Has a hospital made capital investments, such as building or purchasing new facilities, in recent years that increased its costs? Such information could be useful in considering a hospital’s certificate-of-need application. NASHP will continue to refine this tool to integrate potential efficiency and quality measures, but the data on costs is a valuable place to start. The tool’s goal is to provide data to inform discussions between purchasers of care and hospitals.
Officials from several states have reviewed the tool and expressed interest in leveraging what they are learning from its analysis of their hospitals in different ways, such as:
- Pursuing a more robust insurance rate review process to help contain health care cost growth;
- Further informing hospital global budget parameters; and
- Negotiating hospital reimbursement as a reference to Medicare rates.
An early version of this tool, with more limited calculations, was used by the Montana State Employee Health Plan to negotiate with hospitals and providers to establish a reimbursement rate based on Medicare rates.
While the tool includes numerous metrics for analyses, there are several that stand out:
- Financial statements. Net income, reserves, and profit margins are reported for the entire hospital, with no adjustments made for Medicare-disallowed costs. (Medicare disallowed costs include those unrelated to patient care, like research and lobbying, as well as non-patient care-related revenues such as those from hospital cafeterias and parking lots.)
These data points are clearly important to a state or other purchaser in gaining an understanding of some basic information on the financial health of a hospital when pursuing cost-containment measures, as the goal of this initiative is to stem rising health care costs, not impoverish hospitals.
- Cost-to-charge ratio (CCR). The CCR shows the percentage of charges that represent actual operating costs during a one-year period. The ratio generated by the tool is displayed in two formats:
- CCR: This ratio equals costs divided by charges. For example, a CCR of 25 percent means that a hospital’s costs are 25 percent of charges. The lower the percentage, the larger the profit margin on its charges.
- Charges as percentage of costs: This ratio equals charges divided by costs. A ratio of 500 percent means costs are multiplied by – or grossed up – by 500 percent to establish charges.
These ratios are useful when evaluating insurer or third-party administrator (TPA) network discounts off a hospital’s chargemaster rates, which are like list prices for a car and often bear little relation to what providing services actually cost. Insurers often boast about their negotiated discounts with hospitals, but if a hospital’s costs are only 25 percent of its charges, is a discount of 30 percent off chargemaster rates really a good deal?
- Charity care/bad debt/uninsured patients: The NASHP tool specifically uses a hospital’s costs – and not its higher chargemaster rates – for this calculation. Typically, hospitals report their expenses for charity care, bad debt, and services for the uninsured at their chargemaster rates. However, recent changes in accounting rules require these calculations to now be based on costs and, as a result, in their audited financial statements hospitals may no longer report the higher chargemaster rates. While the Centers for Medicare & Medicaid Services and the Internal Revenue Services have not adopted the new accounting rules requiring costs – not chargemaster rates – to be reported, the tool does report at the cost level.
Using costs to indicate a hospital’s uncompensated care is a more accurate representation of this category and can be used to more clearly understand a hospital’s overall profit margin.
- Payer mix: Payer mix is the percentage of hospital patient care charges attributable to Medicare, Medicaid, and commercial – which represents insurers, employer self-insured plans, Veterans Administration, and self-pay, etc.
When assessing hospital costs to develop meaningful cost-containment strategies, the payer mix is important as it helps clarify the hospital’s recovery of costs from each category of payer.
- Profit/loss: NASHP’s tool calculates profit and loss by payer type. Using the global CCR applied to specific payer-type charges, the tool is able to calculate the related costs for each group and its profit margins.
It is important to look at payer mix and profit/loss together. Consider the example highlighted by a NASHP analysis using the tool of one hospital in Colorado:
- The hospital’s data showed a 40 percent loss for Medicaid, but because Medicaid was only 9 percent of the hospital’s payer mix, the loss was limited to only that relatively small portion of the facility’s patient population.
- The same hospital showed a 13 percent profit for Medicare, which comprised 21 percent of its patient population.
- And it reported a 54 percent profit for its commercially-insured patients, who made up 70 percent of its patients.
On the whole, this hospital is profitable. By looking at the payer mix and profit/loss indicators or measures in tandem, policymakers can achieve a clearer, more holistic picture of the financial health of a hospital.
- Multiples of Medicare: The tool also includes hospital payments and costs for commercial payers (commercial insurance, employer self-funded plans, etc.) It calculates the required payments from this segment to allow the hospital to break-even.
- The break-even point is the point at which revenue equals costs, which would result in zero profit and zero loss. Break-even is calculated in the tool in the following way:
- Level 1: Commercial patient costs plus any balance of government program payments, charity care, and uninsured.
- Level 2: Level 1 plus all Medicare-allowed costs.
- Level 3: Levels 1 and 2 plus all Medicare disallowed costs. Physician direct patient costs are not included in the add-back of disallowed costs, as related reimbursement is processed through other channels, such as the Medicare resource-based relative value-scale (RBRVS) physicain payment system, fee schedules, etc.)
- Level 4: Levels 1, 2, and 3 plus hospital non-operating income and expenses.
- The break-even point is the point at which revenue equals costs, which would result in zero profit and zero loss. Break-even is calculated in the tool in the following way:
As states develop budgets for state employee health plans and other public purchasers, and consider developing public option health plans, this tool can be useful to lower costs by developing rates using Medicare as a reference, negotiating increases above Medicare reference rates to account for public payer balances, but that are still lower than their current spending. The tool also helps states find an appropriate rate that can achieve savings but still keep hospitals financially viable. What better data to use than a hospital’s own reported costs?
NASHP staff is available to state officials who may need technical assistance in using the tool, contact Maureen Hensley-Quinn (firstname.lastname@example.org).
Facility fees – designed originally to compensate hospitals for “stand-by” capacity required for emergency departments and inpatient services – are increasingly added to bills for diagnostic testing and other routine services and are raising health care costs. One state employee health plan’s claims show that facility fees charged for COVID-19 testing conducted in outpatient hospital settings ranged from $53 to $150 per test — culminating in $344,589 in additional costs over several months.
Model Act Summary: This model legislation prohibits site-specific facility fees for services rendered at physician practices and clinics located more than 250 yards from a hospital campus. It also prohibits all service-specific facility fees for typical outpatient services that are billed using evaluation and management codes, even if those services are provided on a hospital campus.
The act requires annual reporting of facility fees charged or billed by health care providers, delegates implementation authority to a relevant state agency, and provides three enforcement mechanisms:
- An annual facility fee audit by the relevant state agency;
- A private right of action for consumers; and
- Administrative financial penalties against health care providers for violations.
(1) Definitions. As used in this section,
(A) “Campus” means: (i) a hospital’s main buildings; (ii) the physical area immediately adjacent to a hospital’s main buildings and other areas and structures that are not strictly contiguous to the main buildings but are located within two hundred fifty (250) yards of the main buildings, or (iii) any other area that has been determined on an individual case basis by the Centers for Medicare & Medicaid Services to be part of a hospital’s campus.
(B) “Facility fee” means any fee charged or billed by a health care provider for outpatient services provided in a hospital-based facility [or freestanding emergency facility] that is: (i) Intended to compensate the health care provider for the operational expenses of the health care provider, (ii) separate and distinct from a professional fee; and (iii) regardless of the modality through which the health care services were provided.
(C) “Freestanding emergency facility” means an emergency medical care facility that is licensed under [reference to code section that regulates freestanding emergency facilities], and shall not include urgent care clinics.
(D) “Health system” means: (i) A parent corporation of one or more hospitals and any entity affiliated with such parent corporation through ownership, governance, membership or other means, or (ii) a hospital and any entity affiliated with such hospital through ownership, governance, membership or other means.
(E) “Hospital” is a hospital licensed under [code section for hospital licensure.
(F) “Hospital-based facility” means a facility that is owned or operated, in whole or in part, by a hospital where hospital or professional medical services are provided.
(G) “Professional fee” means any fee charged or billed by a provider for professional medical services provided in a hospital-based facility.
(H) “Health care provider” means an individual, entity, corporation, person, or organization, whether for profit or nonprofit, that furnishes, bills or is paid for health care service delivery in the normal course of business, and includes, without limitation, health systems, hospitals, hospital-based facilities, [freestanding emergency facilities,] and urgent care clinics.
(2) Limits on Facility Fees.
(A) Site-specific limits. No health care provider shall charge, bill, or collect a facility fee, except for: (i) services provided on a hospital’s campus; (ii) services provided at a facility that includes a licensed hospital emergency department[; or (iii) emergency services provided at a licensed freestanding emergency facility].
(B) Service-specific limits. Notwithstanding subsection (A) and whether or not the services are provided on a hospital’s campus, no health care provider shall charge, bill, or collect a facility fee for (i) outpatient evaluation and management services; or (ii) any other outpatient, diagnostic, or imaging services identified by the [Department/Commission] pursuant to subsection (C).
(C) Identification of services. The [Department/Commission] shall annually identify services subject to the limitations on facility fees provided in subsection (B) that may reliably be provided safely and effectively in settings other than hospitals.
(3) Reporting. Each hospital and health system [and freestanding emergency facility] shall submit a report annually to [the Department/Commission] concerning facility fees charged or billed during the preceding calendar year. The report shall be in such format as [Department/Commission] may specify. The [Department/Commission] shall publish the information reported on publicly accessible website designated by the [Department/Commission].
At the discretion of the state pursuing this model, Section 4 (the following language detailing reporting requirements) could be removed from legislation and instead be used to inform implementing regulations promulgated under the model act.
(4) Reporting Requirements. Such report shall include, without limitation, the following information:
(A) The name and full address of each facility owned or operated by the hospital or health system [or freestanding emergency facility] that provides services for which a facility fee is charged or billed;
(B) The number of patient visits at each such hospital-based facility [or freestanding emergency facility] for which a facility fee was charged or billed;
(C) The number, total amount, and range of allowable facility fees paid at each such facility by Medicare, Medicaid, and private insurance;
(D) For each hospital-based facility and for the hospital or health system as a whole [or freestanding emergency facility], the total amount billed and the total revenue received from facility fees;
(E) The top ten procedures or services, identified by current procedural terminology (CPT) category I codes, provided by the hospital or health system [or freestanding emergency facility] overall that generated the greatest amount of facility fee gross revenue, the volume each of these ten procedures or services and gross and net revenue totals, for each such procedure or service, and, for each such procedure or service, the total net amount of revenue received by the hospital or health system [or freestanding emergency facility] derived from facility fees;
(F) The top 10 procedures or services, identified by current procedural terminology (CPT) category I codes, based on patient volume, provided by the hospital or health system [or freestanding emergency facility] overall for which facility fees are billed or charged [based on patient volume], including the gross and net revenue totals received for each such procedure or service;
(G) Any other information related to facility fees that the [Department/Commission] may require.]
(5) Regulatory Authorization. The [Department/Commission] may promulgate regulations necessary to implement this section, specify the format and content of reports, and impose penalties for noncompliance consistent with the department’s authority to regulate health care providers.
(A) Any violation of any provision of this act shall constitute an unfair trade practice pursuant to [reference to code section for state unfair trade practices statute].
(B) A health care provider that violates any provision of this act or the rules and regulations adopted pursuant hereto shall be subject to an administrative penalty of not more than $1,000 per occurrence.
(C) The [Department/Commission] or its designee may audit any health care provider for compliance with the requirements of this section. Until the expiration of [four (4)] years after the furnishing of any services for which a facility fee was charged, billed, or collected, each health care provider shall make available, upon written request of the [Department/Commission] or its designee, copies of any books, documents, records, or data that are necessary for the purposes of completing the audit.
The Centers for Medicare & Medicaid Services (CMS) has proposed a new rule with provisions designed to advance value-based purchasing (VBP) arrangements with drug manufacturers. Comments about the proposal are due July 20, 2020.
State employee health plans (SEHPs), which provide health coverage for millions of public employees, their dependents, and some retirees, are making rapid changes to address the COVID-19 pandemic. This retooling of insurance plans must meet emerging federal requirements and ensure that coverage meets enrollees’ needs while managing costs and anticipating budget constraints.
During a recent teleconference convened by the National Academy for State Health Policy (NASHP), SEHP administrators shared strategies for implementing new federal mandates and highlighted ways they are making changes to other benefit offerings.
Federal mandates: The Family First Coronavirus Response Act and the Coronavirus Aid, Relief, and Assistance Act (CARES Act) added mandates to SEHP coverage, including:
- Any COVID-19 testing, preventive services, treatment, and vaccine are now covered with no member cost sharing.
- Telehealth benefits are to be made widely available and under a high-deductible health plan, these visits are excluded from deductible provisions.
These provisions are designed to reduce immediate individual cost responsibilities that can be a barrier to accessing these services. However, costs are not eliminated, so each SEHP must cover them. During their teleconference, administrators noted that language in the CARES Act requires health plans to reimburse diagnostic testing at the negotiated rate for “items and services,” which is charged by in-network providers. However, out-of-network providers should be reimbursed for the “cash price as listed on public internet websites,” which presents a potentially costly challenge.
SEHP administrators are concerned about these out-of-network claims because they could be expensive, unpredictable, and subject to change throughout the course of the pandemic. NASHP will monitor the impact this CARES Act provision has on SEHPs.
Benefit design: Plan administrators have worked with their governing structures, which in some states include trustees and boards, to make changes that help ensure that enrollees have access to needed care. North Carolina’s SEHP administrator made changes to prior authorization requirements, in addition to other changes. SEHPs across the country also adopted pharmacy refill flexibilities that include paying for refills sooner or covering a greater number of doses, etc. and lifted member non-payment penalties during the COVID-19 emergency.
Plan eligibility: Eligibility for coverage becomes an issue as public entities add temporary staff or reduce employee hours. Washington State is not only extending enrollment paperwork deadlines for new hires, but also implementing a new eligibility policy for targeted new state employees. Effective April 1, 2020, anyone hired or rehired in a specific position type and who works a minimum of eight hours is eligible for benefits with the full employer contribution for benefits. Washington defined the position types as:
- First responders (firefighters, police, EMTs, public safety personnel, etc.);
- Health care professionals (physicians, nurses, pharmacists, behavioral health specialists, etc.);
- Any medical facility position (e.g., health care professionals, lab technicians, administrative staff, sanitation workers, etc.);
- Public health officials; and
- Any COVID-19 research position.
Washington is also extending the maximum number of months for Continuation of Health Coverage (COBRA) and other self-pay coverage options until two months after the state of emergency is lifted.
Monitoring: While SEHP leaders strive to ensure enrollees have access to needed providers without delay, they are stewards of public funds and must be vigilant and aware of opportunists who may take advantage of this crisis, so they must maintain fraud prevention policies. As signature requirements for medical supplies and prescription drugs are eased to ensure access, New Jersey is exploring alternative forms of verification. For example, New Jersey’s SEHP administrator encouraged the plan’s third-party administrators to conduct follow-up phone calls or track data analytics to ensure enrollees received home deliveries of prescriptions or medical supplies.
Telehealth: Many plans are extending telehealth services beyond the requirements mandated by the CARES Act. Specifically, plans are now including mental health and physical therapy care through remote care options, as well as considering maintaining these benefit plan offerings after the pandemic, such as critical substance use services.
These changes and others that are being made as needed to meet the demands for flexibility and new services to respond to the pandemic could be costly. However, the financial impact to these plans is still evolving, and there are many unknowns. But what administrators acknowledged is that initial costs will increase for COVID-19-related hospitalizations, testing, and preventive services. Moving forward, it is anticipated that plan costs will continue to increase as a result of COVID-19 treatments and related vaccines. While COVID-19 costs increase, there has been a corresponding decrease in elective procedures, but administrators don’t know the financial impact of these delayed treatments, elective procedures, and foregone care. SEHPs have funding reserves to cover their immediate cost increases but may need to raise premiums and/or enrollee cost sharing in the future.
SEHP administrators also acknowledged the significant impact of the economic crisis and its immediate impact on reducing state revenues, which will have a serious impact on state budgets that finance SEHPs. One official noted there has already been an $11 million “withhold” from her SEHP budget in response to the dramatic loss of state revenue. NASHP and SEHP leaders will work together to analyze these impacts and will share analytic models to assist SEHPs in projecting impacts to their plan reserves, contributions, and premiums.
Meanwhile, the CARES Act’s Title VI Relief Fund authorizes the US Treasury Department to issue $150 billion in payments to states, tribal governments, and units of local government. The receipt of funds must be used for necessary expenditures due to the COVID-19 public health emergency that were not accounted for in the most recent state budgets and are incurred between March 1 and Dec. 20, 2020. SEHPs may consider working with their respective leaders and executive branch members to determine qualifications for receiving relief funds for their plans.
This new NASHP chart details the amounts and required oversight of COVID-19 federal funds allocated to hospitals, providers, and states by the Families First Act, CARES Act, and HR 266.
States are experiencing a huge rise in the number of people without health insurance in the wake of mass layoffs resulting from the COVID-19 pandemic and are seeking strategies to protect them from high prescription drug prices. The uninsured are sometimes the only consumers left paying the full list price for a drug, while the insured benefit from drug discounts negotiated on their behalf.
Why is creating a state purchasing pool for prescription drugs a good strategy for states?
State purchasing pools for prescription drugs leverage public buying power to reduce drug costs. Today, every state purchases prescription drugs for its employees through its state employee health benefit plan. States are among the largest employers in the state and therefore the state employee health plan – or any other public plan a state administers – can leverage the size of its prescription drug purchasing pool to negotiate better prices for entities participating in a state purchasing pool for prescription drugs.
NASHP’s proposal for a state purchasing pool for prescription drugs provides additional details about this approach. NASHP has also developed model legislation to establish a state purchasing pool for prescription drugs.
How does creating a state purchasing pool for prescription drugs save money?
By expanding the number of people buying prescriptions through a plan, the pool’s purchasing and bargaining power grows to benefit both current state employee health plan enrollees and those who join the prescription purchasing pool.
What about adverse selection?
Concerns about adverse selection, which would be relevant to medical benefits, are not a factor for this model because prescription drug plans do not “pool risk”. Unlike health insurance plans – in which the health of enrollees influences premium costs – prescription drug prices are based on the volume of drugs purchased, not individuals’ health status. The discounts for prescription drug plans are based on the number of covered lives so the more covered lives in a purchasing pool, the greater the savings due to the increased purchasing power of the plan.
Who could join a state purchasing pool for prescription drugs?
Health insurance carriers offering plans to individuals and small and large businesses could all participate in a state purchasing pool for prescription drugs. Self-funded employer plans could also participate.
Non-state public employers such as municipalities, counties, state universities, and public school teachers could also participate.
Could the uninsured participate?
Uninsured individuals could be given access to a drug discount card to allow them to access the discounted drug prices available to state employees and other members of the purchasing pool. While the state would enable access to the discounted prices it negotiates, it would not pay for the drugs purchased by the uninsured who use the discount card. Uninsured individuals using the discount card would pay for their own prescription drug costs, but they would benefit from the deep discounts the state was able to negotiate via the purchasing pool.
Would a state employee prescription drug plan lose its ERISA-exemption if it allowed non-state employers to participate in the purchasing pool?
A state employee prescription drug plan can maintain its government exemption under the Employee Retirement Income Security Act (ERISA) by creating an administratively separate – but coordinated – state drug purchasing pool in which both the state employee prescription drug plan and self-funded employers can participate. NASHP’s proposal for a purchasing pool provides details on strategies for structuring and implementing a state drug purchasing pool to avoid potential legal and regulatory challenges.
How could potential purchasing pool participants determine if they would save money?
Potential purchasing pool participants could share information about specific drugs and quantities they currently purchase for their members with the administrator of the purchasing pool, such as a sample claims file for a given period of time. All information would be treated as confidential. Proprietary information about pricing for specific drugs would not be required.
The administrator of the state purchasing pool could run the prospective participant’s sample claims experience through the pool’s cost model and the state could then offer aggregate information detailing what the potential pool participant would spend for those drugs if they joined the pool. The potential pool participants could then compare that number to their current costs in order to determine whether they would save by joining the pool.
Would it be necessary to align prescription drug benefits and formularies to participate in the drug purchasing pool?
Depending on the pharmacy benefit manager (PBM) and the plans in question, it may not be necessary to align benefits (e.g., copays, deductibles, and coinsurance) and formularies, in order to achieve savings. However, an even deeper level of savings could be realized if participants do elect to align benefits and formularies.
Are there examples of this approach working successfully?
The City of Hartford joined a prescription drug purchasing pool with the Connecticut state employee drug benefit plan in 2012 after legislative authority opened up the state employee drug plan to municipalities and other public employers. Hartford maintained its own drug benefit design. The contract between Hartford and the PBM was separate from the state’s, but included the same base contract terms found in the PBM and state employees’ contract. This alignment allowed Hartford to access the larger drug discounts available to state employees and to realize significant savings – more than $1 million annually – or about 10 percent of its prescription drug spend.
As more entities join a drug purchasing pool, the increase in participants creates a win-win scenario. As the volume of drugs purchased grows, the purchasing pool’s negotiating power increases, resulting in lower drug prices for all participants.
How does the purchasing pool model fit in with NASHP’s model PBM contract terms?
The efficacy of NASHP’s model legislation to allow buy-in into state purchasing pools for prescription drugs depends on the ability of a state’s employee drug plan to secure favorable contact terms with its PBM in order to secure the best pricing deals for participants. The first step in implementing this model is to ensure that the state’s contract with the PBM managing its drug benefit reflects best practices in PBM contracting. NASHP has released model PBM contract terms for that purpose. NASHP developed the model PBM contract terms based on input from states that have secured favorable terms in their PBM contracts to maximize cost-savings on prescription drugs. Key provisions include:
- Administrative-fee only compensation;
- 100 percent pass-through of rebates and revenues;
- Cost-trend and pricing guarantees;
- Transparency; and
- Member cost-sharing protections.
Once a state has established a favorable contract with a PBM that includes these terms, the next step is to allow other purchasers (insurance carriers, self-funded employers, and other public employers) to benefit by establishing a state prescription drug purchasing pool.
NASHP helps state leaders advance legislation to contain prescription drug prices and tracks states’ efforts at its Rx State Legislative Tracker. State officials who are interested in developing a state purchasing pool for prescription drugs can contact Jennifer Reck (email@example.com) for additional information.